Immediate Impact
3 by Nobel laureates 1 from Science/Nature 51 standout
Citing Papers
Emerging role of exosomes in cancer therapy: progress and challenges
2025 Standout
The hallmarks of cancer immune evasion
2024 Standout
Works of Kohei Omatsu being referenced
807O Nivolumab versus gemcitabine or pegylated liposomal doxorubicin for patients with platinum-resistant (advanced or recurrent) ovarian cancer: Open-label, randomized trial in Japan (NINJA trial)
2020
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Kohei Omatsu | 325 | 239 | 119 | 58 | 538 | |
| Liron Kogan | 234 | 207 | 139 | 52 | 607 | |
| Kazuya Ariyoshi | 334 | 339 | 84 | 34 | 590 | |
| Donald E. Marsden | 255 | 309 | 163 | 38 | 621 | |
| Francesca Ciccarone | 314 | 321 | 104 | 51 | 608 | |
| Tomoyuki Ichimura | 252 | 204 | 56 | 46 | 515 | |
| Dae Hoon Jeong | 320 | 191 | 73 | 40 | 576 | |
| Mustafa Zelal Muallem | 254 | 266 | 185 | 56 | 530 | |
| Ilaria Sabatucci | 267 | 214 | 150 | 35 | 522 | |
| Hidetaka Nomura | 388 | 304 | 149 | 76 | 597 | |
| Rosanna Mancari | 225 | 341 | 107 | 33 | 596 |
All Works
Login with ORCID to disown or claim papers
Loading papers...